WallStreetZenWallStreetZen

NASDAQ: SAGE
Sage Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SAGE

Based on 14 analysts offering 12 month price targets for Sage Therapeutics Inc.
Min Forecast
$4.00-41.26%
Avg Forecast
$12.21+79.35%
Max Forecast
$25.00+267.11%

Should I buy or sell SAGE stock?

Based on 14 analysts offering ratings for Sage Therapeutics Inc.
Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 7.14%
Hold
10 analysts 71.43%
Sell
2 analysts 14.29%
Strong Sell
1 analysts 7.14%

Be the first to know when Wall Street analysts revise their SAGE stock forecasts and price targets.

SAGE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-10-09
lockedlocked$00.00+00.00%2024-10-09
lockedlocked$00.00+00.00%2024-10-09
lockedlocked$00.00+00.00%2024-10-09
lockedlocked$00.00+00.00%2024-10-04
Truist Securities
Top 2%
99
HoldMaintains$13.00+90.90%2024-08-14
JP Morgan
Top 24%
77
HoldMaintains$10.00+46.84%2024-08-06
TD Cowen
Bottom 2%
2
HoldDowngrades$10.00+46.84%2024-07-30
Goldman Sachs
Bottom 46%
46
HoldMaintains$11.00+61.53%2024-07-26
ScotiaBank
Top 45%
56
BuyMaintains$17.00+149.63%2024-07-25

1 of 2

Forecast return on equity

Is SAGE forecast to generate an efficient return?
Company
-2.03%
Industry
-781%
Market
49.42%
SAGE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SAGE forecast to generate an efficient return on assets?
Company
-1.83%
Industry
25.95%
SAGE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SAGE earnings per share forecast

What is SAGE's earnings per share in the next 3 years based on estimates from 13 analysts?
Avg 1 year Forecast
-$6.46
Avg 2 year Forecast
-$5.09
Avg 3 year Forecast
-$3.06

SAGE revenue forecast

What is SAGE's revenue in the next 3 years based on estimates from 11 analysts?
Avg 1 year Forecast
$40.1M-58.76%
Avg 2 year Forecast
$103.5M+6.42%
Avg 3 year Forecast
$173.6M+78.52%
SAGE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SAGE revenue growth forecast

How is SAGE forecast to perform vs Biotechnology companies and vs the US market?
Company
21%
Industry
35.39%
Market
9.86%
SAGE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SAGE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SAGE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SAGE$6.81$12.21+79.35%Hold
MNMD$5.81$27.71+377.01%Strong Buy
FHTX$7.43$16.00+115.34%Buy
CTNM$16.46$28.67+74.16%Strong Buy
TSHA$1.99$6.38+220.35%Strong Buy
View Top Biotech Stocks

Sage Therapeutics Stock Forecast FAQ

Is Sage Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NASDAQ: SAGE) stock is to Hold SAGE stock.

Out of 14 analysts, 0 (0%) are recommending SAGE as a Strong Buy, 1 (7.14%) are recommending SAGE as a Buy, 10 (71.43%) are recommending SAGE as a Hold, 2 (14.29%) are recommending SAGE as a Sell, and 1 (7.14%) are recommending SAGE as a Strong Sell.

If you're new to stock investing, here's how to buy Sage Therapeutics stock.

What is SAGE's earnings growth forecast for 2024-2026?

(NASDAQ: SAGE) Sage Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.51%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.85%.

Sage Therapeutics's earnings in 2024 is -$445,673,000.On average, 13 Wall Street analysts forecast SAGE's earnings for 2024 to be -$394,617,692, with the lowest SAGE earnings forecast at -$425,521,413, and the highest SAGE earnings forecast at -$333,945,786. On average, 13 Wall Street analysts forecast SAGE's earnings for 2025 to be -$310,557,371, with the lowest SAGE earnings forecast at -$442,615,531, and the highest SAGE earnings forecast at -$195,361,338.

In 2026, SAGE is forecast to generate -$186,948,590 in earnings, with the lowest earnings forecast at -$374,849,567 and the highest earnings forecast at $42,735,293.

What is SAGE's revenue growth forecast for 2024-2026?

(NASDAQ: SAGE) Sage Therapeutics's forecast annual revenue growth rate of 21% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.39%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.86%.

Sage Therapeutics's revenue in 2024 is $97,244,000.On average, 11 Wall Street analysts forecast SAGE's revenue for 2024 to be $2,448,304,913, with the lowest SAGE revenue forecast at $2,159,597,486, and the highest SAGE revenue forecast at $3,333,352,823. On average, 11 Wall Street analysts forecast SAGE's revenue for 2025 to be $6,317,741,456, with the lowest SAGE revenue forecast at $2,951,177,206, and the highest SAGE revenue forecast at $11,917,041,594.

In 2026, SAGE is forecast to generate $10,598,230,464 in revenue, with the lowest revenue forecast at $5,572,682,155 and the highest revenue forecast at $21,923,815,608.

What is SAGE's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: SAGE) forecast ROA is -1.83%, which is lower than the forecast US Biotechnology industry average of 25.95%.

What is SAGE's Price Target?

According to 14 Wall Street analysts that have issued a 1 year SAGE price target, the average SAGE price target is $12.21, with the highest SAGE stock price forecast at $25.00 and the lowest SAGE stock price forecast at $4.00.

On average, Wall Street analysts predict that Sage Therapeutics's share price could reach $12.21 by Oct 9, 2025. The average Sage Therapeutics stock price prediction forecasts a potential upside of 79.35% from the current SAGE share price of $6.81.

What is SAGE's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: SAGE) Sage Therapeutics's current Earnings Per Share (EPS) is -$7.41. On average, analysts forecast that SAGE's EPS will be -$6.46 for 2024, with the lowest EPS forecast at -$6.97, and the highest EPS forecast at -$5.47. On average, analysts forecast that SAGE's EPS will be -$5.09 for 2025, with the lowest EPS forecast at -$7.25, and the highest EPS forecast at -$3.20. In 2026, SAGE's EPS is forecast to hit -$3.06 (min: -$6.14, max: $0.70).

What is SAGE's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: SAGE) forecast ROE is -2.03%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.